* If you want to update the article please login/register
Patients with newly diagnosed advanced ovarian cancer who are scheduled to receive neoadjuvant therapy are expected to receive neoadjuvant therapy in a schedule dependent sequence with specific cycles of a common six-cycle chemotherapy regimen.
Source link: https://clinicaltrials.gov/ct2/show/NCT05605535
* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions